Skip to content
All news
Regulatory

DOJ Charges 324 Defendants in Largest Medicare Fraud Takedown: $14.6 Billion

The U.S. Department of Justice charged 324 defendants in the largest Medicare fraud takedown in history, involving $14.6 billion in losses. The amount more than doubles the previous record of $6 billion set a year earlier. The fraud includes billing for services never provided and denying patients necessary scans.

May 6, 2026
2 min read
Source: 24/7 Wall St.
Share:

Key Numbers

defendants
324
losses
14.6B
previous record
6B

The U.S. Department of Justice (DOJ) announced charges against 324 defendants in the largest Medicare fraud takedown ever, with estimated losses of $14.6 billion. This figure more than doubles the previous record of $6 billion set just one year earlier.

Details of the Action

The case involves allegations of billing for medical services never provided, as well as denying patients necessary scans such as PET scans based on false records. The DOJ noted that the fraud increasingly appears as line items on retirees' statements, such as copays for services they never received.

Company Response

UnitedHealth Group (UNH) and other affected health insurers have not yet commented. UnitedHealth is the largest health insurer in the U.S. and administers Medicare Advantage plans.

Precedents and Context

This takedown is part of an ongoing DOJ crackdown on healthcare fraud, which has escalated in recent years. The previous record was $6 billion in 2024.

Potential Financial Impact

The case is expected to increase regulatory scrutiny on health insurers and Medicare providers, potentially raising compliance costs and impacting profits. It may also lead to changes in billing and reimbursement policies.

Frequently Asked Questions

The losses amount to $14.6 billion, more than double the previous record of $6 billion.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.